Sponsored by Pfizer Oncology

Program Description

Please join Neil Iyengar, MD, as he reviews a treatment option for patients with hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC). Today’s presentation will feature select data and include patient case discussions to help highlight patient and clinical characteristics that are commonly considered for disease management. As a part of the patient treatment journey, dosing, and monitoring information will be presented.

Speaker

Neil Iyengar, MD
Atlanta, Georgia